USES OF IMMUNOCONJUGATS TARGETING CD138
- 专利权人:
- BIOTEST AG;IMMUNOGEN, INC.
- 发明人:
- 申请号：
- IL21616611
- 公开号：
- IL216166D0
- 申请日:
- 2011.11.06
- 申请国别(地区):
- IL
- 年份:
- 2012
- 代理人:
- 摘要：
- Disclosed are methods and treatment regimes that include the administration of immunconjugates targeting CD138 to combat diseases. The immunoconjugate is either used as the sole active ingredient, as part of a treatment regime or as part of an anticancer combination.
- 来源网站：
- 中国工程科技知识中心
